Literature DB >> 10022292

Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification.

K W Turteltaub1, K H Dingley.   

Abstract

DNA adducts are nucleotide bases that have been covalently modified by reactive electrophilic chemical intermediates, and have been extensively researched for their role in mutagenesis and carcinogenesis. However, many DNA adduct measurement techniques have difficulty in the quantification of adducts at realistic human exposure levels. We are using the extremely sensitive analytical technique of accelerator mass spectrometry (AMS) to study adducts either at low dose or directly in humans. AMS is a technique for measuring isotope ratios with high selectivity, attomole sensitivity (10(-18) mol) and precision of 0.5-10%, depending on isotope level and preparation method. This sensitivity and precision is being used to study the dose-response, toxicokinetics, and toxicodynamics of DNA adduct formation and removal following administration of very low doses of chemicals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10022292     DOI: 10.1016/s0378-4274(98)00344-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  10 in total

Review 1.  Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl.

Authors:  Zhidan Chen; Yuesheng Zhang; Paul Vouros
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-04-24       Impact factor: 3.205

Review 2.  Quantifying exploratory low dose compounds in humans with AMS.

Authors:  Stephen R Dueker; Le T Vuong; Peter N Lohstroh; Jason A Giacomo; John S Vogel
Journal:  Adv Drug Deliv Rev       Date:  2010-10-31       Impact factor: 15.470

3.  Quantitative metabolism using AMS: Choosing a labeled precursor.

Authors:  Jennifer Links; Magnus Palmblad; Ted Ognibene; Ken Turteltaub; Graham Bench
Journal:  Nucl Instrum Methods Phys Res B       Date:  2010-04-01       Impact factor: 1.377

Review 4.  Phase 0/microdosing approaches: time for mainstream application in drug development?

Authors:  Tal Burt; Graeme Young; Wooin Lee; Hiroyuki Kusuhara; Oliver Langer; Malcolm Rowland; Yuichi Sugiyama
Journal:  Nat Rev Drug Discov       Date:  2020-09-08       Impact factor: 84.694

5.  Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometer.

Authors:  Erin E Bessette; Angela K Goodenough; Sophie Langouët; Isil Yasa; Ivan D Kozekov; Simon D Spivack; Robert J Turesky
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

6.  Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.

Authors:  Sisi Wang; Hongyong Zhang; Michael Malfatti; Ralph de Vere White; Primo N Lara; Kenneth Turteltaub; Paul Henderson; Chong-xian Pan
Journal:  Chem Res Toxicol       Date:  2010-10-28       Impact factor: 3.739

7.  Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity.

Authors:  Shuai Jiang; Amy W Pan; Tzu-yin Lin; Hongyong Zhang; Michael Malfatti; Kenneth Turteltaub; Paul T Henderson; Chong-xian Pan
Journal:  Chem Res Toxicol       Date:  2015-11-11       Impact factor: 3.739

8.  The vanishing zero revisited: thresholds in the age of genomics.

Authors:  Helmut Zarbl; Michael A Gallo; James Glick; Ka Yee Yeung; Paul Vouros
Journal:  Chem Biol Interact       Date:  2010-01-28       Impact factor: 5.192

9.  Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.

Authors:  Rozaini Abdullah; Sebastiaan Wesseling; Bert Spenkelink; Jochem Louisse; Ans Punt; Ivonne M C M Rietjens
Journal:  J Appl Toxicol       Date:  2020-07-07       Impact factor: 3.446

Review 10.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.